Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
Thomas J. Walsh(Cornell University), Z. Erjavec(National Institutes of Health), David A. Stevens(Stanford University), Thomas F. Patterson(National Institute of Allergy and Infectious Diseases), J. Ritter(National Institutes of Health), P. M. Shah(National Institutes of Health), Dominik Selleslag(National Institutes of Health), John Rex(Princeton University), Olivier Lortholary(Hôpital Necker-Enfants Malades), Ben de Pauw(Radboud University Medical Center), F. Crokaert(National Institutes of Health), J. Peter Donnelly(Baylor College of Medicine), John E. Bennett(National Institute of Allergy and Infectious Diseases), David W. Denning(Manchester Academic Health Science Centre), Johan Maertens(Unknown), Jacques Billé(University Hospital of Lausanne), Jacques F. Meis(Radboud University Nijmegen), D Fière(National Institutes of Health), J. E. Edwards(National Institutes of Health)
Cited by 2,338
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2015|4k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.2k
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
|Clinical Infectious Diseases|2005|3k